← Back to Search

A1Control App for Diabetes Management in Youth

N/A
Recruiting
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4, 8, and 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a diabetes app to help youth manage their diabetes better in their own homes.

Who is the study for?
This trial is for young people aged 10-18 with type 1 diabetes for over a year, who are already using an insulin pump or hybrid closed-loop therapy for at least six months. It's not suitable for those with significant learning disabilities, pregnant individuals, or those unable to read and write in English.
What is being tested?
The study is testing the use of a mobile health (mHealth) app designed to educate youth on diabetes technology. Participants will use this app at home over a period of 12 weeks to see how feasible and helpful it is.
What are the potential side effects?
Since this trial involves an educational application rather than medication, traditional side effects are not applicable. However, participants may experience issues related to app usability or challenges integrating the tool into daily life.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4, 8, and 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4, 8, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Measure of Engagement in Personal Healthcare
Secondary study objectives
Glycemic control

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: All ParticipantsExperimental Treatment1 Intervention
All participants will perform the same study activities

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
871 Previous Clinical Trials
655,719 Total Patients Enrolled

Media Library

All Participants Clinical Trial Eligibility Overview. Trial Name: NCT05953532 — N/A
Patient Engagement Research Study Groups: All Participants
Patient Engagement Clinical Trial 2023: All Participants Highlights & Side Effects. Trial Name: NCT05953532 — N/A
All Participants 2023 Treatment Timeline for Medical Study. Trial Name: NCT05953532 — N/A
~0 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top